MADHAVBAUG (MADHAVBAUG) fundamentals
MADHAVBAUG is a listed company, part of the Healthcare Services sector, listed on the NSE as MADHAVBAUG (ISIN INE0JR301013). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What MADHAVBAUG does
Vaidya Sane Ayurved Laboratories Limited is an India-based company, which is engaged in research and development in ayurvedic medicines and the sale of ayurvedic medicines and products through its various franchises and own clinics. The Company is also involved in providing ayurved medical professional services across its various clinics, including panchkarma and other ayurvedic treatments through the running of ayurvedic hospitals. The Company operates under brand Madhavbaug. It uses diagnostics, diet, physiotherapy and ayurveda to provide heart disease, diabetes, hypertension and obesity reversal treatments to its patients. The Company operates approximately 360 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi, Punjab, Uttarakhand, West Bengal, and Chhattisgarh. The Company operates three cardiac prevention and rehabilitation hospitals in Khopoli, Kondhali, and Vishakhapatnam.
Valuation and market data
| Last close | ₹146.45 |
|---|---|
| Market capitalisation | ₹155 crore |
| Enterprise value | ₹157 crore |
| P/E (TTM) | 0.00 |
| Price to book | 2.48 |
| Price to sales (TTM) | 0.00 |
| Book value per share | ₹59.13 |
| Dividend yield | 0.00% |
| Sector | Healthcare Services |
| Industry | — |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹102 crore | ₹6 crore | ₹5 crore | 0.00 |
| Mar 2025 | ₹89 crore | ₹7 crore | ₹5 crore | 4.66 |
| Mar 2024 | ₹99 crore | ₹1 crore | ₹1 crore | 0.99 |
| Mar 2023 | ₹100 crore | ₹7 crore | ₹5 crore | 4.94 |
| Mar 2022 | ₹75 crore | ₹5 crore | ₹3 crore | 8.00 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Mar 2026:
| Promoters | 66.3% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 33.7% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.